| The Perseus computational platform for comprehensive analysis of (prote) omics data S Tyanova, T Temu, P Sinitcyn, A Carlson, MY Hein, T Geiger, M Mann, ... Nature methods 13 (9), 731-740, 2016 | 6028 | 2016 |
| Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry M Bassani-Sternberg, E Bräunlein, R Klar, T Engleitner, P Sinitcyn, ... Nature communications 7 (1), 13404, 2016 | 610 | 2016 |
| Visualization of LC‐MS/MS proteomics data in MaxQuant S Tyanova, T Temu, A Carlson, P Sinitcyn, M Mann, J Cox Proteomics 15 (8), 1453-1456, 2015 | 250 | 2015 |
| Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome N Grassl, NA Kulak, G Pichler, PE Geyer, J Jung, S Schubert, P Sinitcyn, ... Genome medicine 8 (1), 1-13, 2016 | 206 | 2016 |
| The ER membrane protein complex interacts cotranslationally to enable biogenesis of multipass membrane proteins MJ Shurtleff, DN Itzhak, JA Hussmann, NT Schirle Oakdale, EA Costa, ... Elife 7, e37018, 2018 | 174 | 2018 |
| Computational methods for understanding mass spectrometry–based shotgun proteomics data P Sinitcyn, JD Rudolph, J Cox Annual Review of Biomedical Data Science 1, 207-234, 2018 | 146 | 2018 |
| MaxDIA enables library-based and library-free data-independent acquisition proteomics P Sinitcyn, H Hamzeiy, F Salinas Soto, D Itzhak, F McCarthy, C Wichmann, ... Nature biotechnology 39 (12), 1563-1573, 2021 | 118 | 2021 |
| MaxQuant goes linux P Sinitcyn, S Tiwary, J Rudolph, P Gutenbrunner, C Wichmann, Ş Yılmaz, ... Nature methods 15 (6), 401-401, 2018 | 37 | 2018 |
| Global detection of human variants and isoforms by deep proteome sequencing P Sinitcyn, AL Richards, RJ Weatheritt, DR Brademan, H Marx, ... Nature Biotechnology, 1-11, 2023 | 35 | 2023 |
| Progress and challenges in mass spectrometry-based analysis of antibody repertoires I Snapkov, M Chernigovskaya, P Sinitcyn, K Lê Quý, TA Nyman, V Greiff Trends in Biotechnology 40 (4), 463-481, 2022 | 25 | 2022 |
| Translatome and transcriptome analysis of TMA20 (MCT-1) and TMA64 (eIF2D) knockout yeast strains DS Makeeva, AS Lando, A Anisimova, AA Egorov, MD Logacheva, ... Data in brief 23, 103701, 2019 | 12 | 2019 |
| A novel uORF-based regulatory mechanism controls translation of the human MDM2 and eIF2D mRNAs during stress KA Akulich, PG Sinitcyn, DS Makeeva, DE Andreev, IM Terenin, ... Biochimie 157, 92-101, 2019 | 12 | 2019 |
| MaxQuant module for the identification of genomic variants propagated into peptides P Sinitcyn, M Gerwien, J Cox Proteomics in Systems Biology: Methods and Protocols, 339-347, 2022 | 5 | 2022 |
| Deep and fast label-free Dynamic Organellar Mapping JP Schessner, V Albrecht, AK Davies, P Sinitcyn, GHH Borner Nature Communications 14 (1), 5252, 2023 | | 2023 |
| Multi-targeted therapy resistance via drug-induced secretome fucosylation MBD Aldonza, J Cha, I Yong, J Ku, P Sinitcyn, D Lee, RE Cho, ... Elife 12, e75191, 2023 | | 2023 |
| One-Hour Phosphoproteome Analysis with the Orbitrap Astral Mass Spectrometer NM Lancaster, P Sinitcyn, P Forny, TM Peters-Clarke, C Fecher, AJ Smith, ... bioRxiv, 2023.11. 21.568149, 2023 | | 2023 |
| An accurate large-scale human E3 ligase concentration map for next-generation TPD-based precision medicine created by MaxQuantAtlas D Ferretti, Y Shi, P Sinitcyn, S Tiwary, C Browne, S Rusin, E Kuhn, ... Molecular & Cellular Proteomics 21 (8), S55-S55, 2022 | | 2022 |
| Development of computational methods for the analysis of proteomics and next generation sequencing data P Sinitcyn lmu, 2021 | | 2021 |
